• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的突变模式及其与预后的关系。

Mutation patterns in colorectal cancer and their relationship with prognosis.

作者信息

Su Zhaoran, El Hage Maria, Linnebacher Michael

机构信息

Department of Gastrointestinal Surgery, People's Hospital of Tongling City, China.

College of Mathematics and Computer Science, Tongling University, Tongling 244000, China.

出版信息

Heliyon. 2024 Aug 20;10(17):e36550. doi: 10.1016/j.heliyon.2024.e36550. eCollection 2024 Sep 15.

DOI:10.1016/j.heliyon.2024.e36550
PMID:39263143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387246/
Abstract

BACKGROUND

Colorectal cancer (CRC) is a prevalent malignancy and a leading cause of cancer-related mortality. Extensive research into the aetiology of CRC has revealed that somatic mutations in certain genes play a crucial role in CRC development.AIM: In this study, we utilized data from public databases to investigate prevalent mutation patterns in CRC and developed a prognostic predictive model for CRC patients based on mutant genetic characteristics and other relevant clinical features.

METHODS

We initially gathered mutation information from CRC patients by analysing data from 15 datasets to identify genes with a mutation frequency of ≥10 %. Next, log-rank analyses were used to determine the relationship between prognosis and the mutational status of the most commonly mutated genes; the SIGnaling database was utilized to generate a protein‒protein interaction network. We consolidated and classified the gene mutation patterns of CRC patients in the database based on frequently mutated genes related to prognosis. A predictive nomogram was constructed, including age, sex, TNM stage, and mutation partner, based on available clinical, mutational, and prognostic information for CRC patients at our institution. Finally, the reliability of the model was verified using time-dependent ROC curve analysis.

RESULTS

The top 7 genes somatically mutated ≥10 % in 4477 samples from 4255 patients were (67 %), (66 %), (43 %), (18 %), (14 %), (14 %), and (10 %). Log-rank analysis demonstrated that the mutation status of 5 genes, namely, , , , , and , correlated significantly with prognosis. Protein‒protein interaction analysis confirmed functional interactions between these 5 genes, implicating them in tumorigenesis. We exhaustively enumerated the mutation patterns involving these five genes in 4255 patients, resulting in identification of 32 mutational patterns. After consolidation and classification, these patterns were divided into 3 grades based on patient prognosis. Next, a predictive nomogram based on the clinical, mutational, and prognostic information of 107 CRC patients treated at University Medical Center Rostock was constructed. The area under the curve (AUC) values for the model for predicting 1-, 3-, and 5-year overall survival were 0.779, 0.721, and 0.815, respectively.

CONCLUSION

Common mutational patterns based on frequently mutated genes are associated with prognosis in CRC patients. Our study provides a valuable and concise prognostic predictor for determining outcomes in patients with CRC.

摘要

背景

结直肠癌(CRC)是一种常见的恶性肿瘤,也是癌症相关死亡的主要原因。对CRC病因的广泛研究表明,某些基因的体细胞突变在CRC发展中起关键作用。

目的

在本研究中,我们利用公共数据库的数据调查CRC中普遍的突变模式,并基于突变基因特征和其他相关临床特征为CRC患者开发一种预后预测模型。

方法

我们首先通过分析15个数据集的数据收集CRC患者的突变信息,以识别突变频率≥10%的基因。接下来,采用对数秩分析确定预后与最常见突变基因的突变状态之间的关系;利用SIGnaling数据库生成蛋白质-蛋白质相互作用网络。我们根据与预后相关的频繁突变基因,对数据库中CRC患者的基因突变模式进行整合和分类。基于我们机构CRC患者的可用临床、突变和预后信息,构建了一个预测列线图,包括年龄、性别、TNM分期和突变伙伴。最后,使用时间依赖性ROC曲线分析验证模型的可靠性。

结果

在来自4255例患者的4477个样本中,体细胞突变≥10%的前7个基因分别是(67%)、(66%)、(43%)、(18%)、(14%)、(14%)和(10%)。对数秩分析表明,5个基因,即、、、和的突变状态与预后显著相关。蛋白质-蛋白质相互作用分析证实了这5个基因之间的功能相互作用,表明它们参与肿瘤发生。我们详尽列举了4255例患者中涉及这五个基因的突变模式,从而识别出32种突变模式。经过整合和分类后,这些模式根据患者预后分为3个等级。接下来,基于罗斯托克大学医学中心治疗的107例CRC患者的临床、突变和预后信息构建了一个预测列线图。预测1年、3年和5年总生存的模型的曲线下面积(AUC)值分别为0.779、0.721和0.815。

结论

基于频繁突变基因的常见突变模式与CRC患者的预后相关。我们的研究为确定CRC患者的预后提供了一种有价值且简洁的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/009c2fc61a4d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/a50f212e5d19/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/3615674afe77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/44b1964eeb44/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/d2e1acde77be/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/009c2fc61a4d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/a50f212e5d19/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/3615674afe77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/44b1964eeb44/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/d2e1acde77be/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8e/11387246/009c2fc61a4d/gr5.jpg

相似文献

1
Mutation patterns in colorectal cancer and their relationship with prognosis.结直肠癌的突变模式及其与预后的关系。
Heliyon. 2024 Aug 20;10(17):e36550. doi: 10.1016/j.heliyon.2024.e36550. eCollection 2024 Sep 15.
2
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.结直肠癌患者的多基因突变特征:用于诊断、病理分类、分期和预后预测。
BMC Cancer. 2021 Apr 9;21(1):380. doi: 10.1186/s12885-021-08108-9.
3
Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.基于下一代测序的粪便基因检测用于结直肠癌诊断。
World J Gastroenterol. 2022 Jul 7;28(25):2920-2936. doi: 10.3748/wjg.v28.i25.2920.
4
Mutational Status of and Affects Clinical Outcome in -Mutated Metastatic Colorectal Cancer.[基因名称1]和[基因名称2]的突变状态影响[特定基因]突变型转移性结直肠癌的临床结局。
Cancers (Basel). 2022 Nov 30;14(23):5921. doi: 10.3390/cancers14235921.
5
Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.207 例结直肠癌患者福尔马林固定石蜡包埋标本中 22 基因panel 多重基因检测的临床意义。
Int J Clin Oncol. 2019 Feb;24(2):141-152. doi: 10.1007/s10147-018-1377-1. Epub 2019 Jan 5.
6
Molecular spectrum of , , , , , and somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.阿拉伯结直肠癌患者中KRAS、NRAS、BRAF、PIK3CA、AKT1和FBXW7体细胞基因突变的分子谱:频率和分布模式的确定
J Gastrointest Oncol. 2016 Dec;7(6):882-902. doi: 10.21037/jgo.2016.11.02.
7
Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.1/2/3类BRAF突变型结直肠癌的临床特征及突变分析
Chin Clin Oncol. 2024 Feb;13(1):3. doi: 10.21037/cco-23-117. Epub 2024 Feb 5.
8
Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.全面分析基因组突变特征和肿瘤突变负担对肝内胆管癌预后的影响。
BMC Cancer. 2021 Feb 3;21(1):112. doi: 10.1186/s12885-021-07788-7.
9
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.结直肠癌中的新型复发性突变基因及预后突变特征
Gut. 2015 Apr;64(4):636-45. doi: 10.1136/gutjnl-2013-306620. Epub 2014 Jun 20.
10
Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.基于扩增子的靶向下一代测序检测的性能验证及 648 例中国结直肠癌患者的突变分析。
Virchows Arch. 2018 Jun;472(6):959-968. doi: 10.1007/s00428-018-2359-4. Epub 2018 Apr 28.

引用本文的文献

1
Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review).结直肠癌的精准溶瘤病毒疗法:用于个性化治疗的基因靶向和免疫调节(综述)
Int J Mol Med. 2025 Jul;56(1). doi: 10.3892/ijmm.2025.5545. Epub 2025 May 9.

本文引用的文献

1
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.Oncomicrobial 群落分析鉴定结直肠癌的临床分子和预后亚型。
Gastroenterology. 2023 Jul;165(1):104-120. doi: 10.1053/j.gastro.2023.03.205. Epub 2023 Mar 16.
2
Colorectal cancer statistics, 2023.2023 年结直肠癌统计数据。
CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1.
3
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
综合临床和基因组分析鉴定出结肠炎相关癌症的驱动事件和分子进化。
Nat Commun. 2023 Jan 7;14(1):110. doi: 10.1038/s41467-022-35592-9.
4
Molecular Classification of Appendiceal Adenocarcinoma.阑尾腺癌的分子分类。
J Clin Oncol. 2023 Mar 10;41(8):1553-1564. doi: 10.1200/JCO.22.01392. Epub 2022 Dec 9.
5
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.结直肠癌中获得性 KRASG12C-EGFR 抑制耐药的分子特征。
Cancer Discov. 2023 Jan 9;13(1):41-55. doi: 10.1158/2159-8290.CD-22-0405.
6
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.直肠癌新辅助治疗反应的基因组和转录组决定因素。
Nat Med. 2022 Aug;28(8):1646-1655. doi: 10.1038/s41591-022-01930-z. Epub 2022 Aug 15.
7
Integrated multi-omics characterization of KRAS mutant colorectal cancer.KRAS 突变型结直肠癌的综合多组学特征分析
Theranostics. 2022 Jul 4;12(11):5138-5154. doi: 10.7150/thno.73089. eCollection 2022.
8
Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.治疗初治结直肠癌中 RAS 热点和 BRAF V600E 突变的同细胞共发生。
JCO Precis Oncol. 2022 Mar;6:e2100365. doi: 10.1200/PO.21.00365.
9
Genome-Wide Mutation Scoring for Machine-Learning-Based Antimicrobial Resistance Prediction.基于全基因组突变评分的机器学习抗菌药物耐药性预测
Int J Mol Sci. 2021 Dec 2;22(23):13049. doi: 10.3390/ijms222313049.
10
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights.对西非结直肠癌患者的分子和表型分析揭示了生物学见解。
Nat Commun. 2021 Nov 24;12(1):6821. doi: 10.1038/s41467-021-27106-w.